on August 29, 2026
Human longevity is one of the most complex biological phenomena studied by modern medicine. For many years, research has sought to identify individual genetic makeup as the primary explanation for differences in lifespan and the likelihood of developing age-related diseases. Today, this perspective remains fundamental, but it is no longer sufficient. The available evidence indicates that the trajectory of aging derives from the continuous interaction between genetic makeup, epigenetic regulation, metabolism, environment, lifestyle, and the microbial communities living in symbiosis with the human organism.
Genomics therefore represents a meeting point between different disciplines. The nuclear genome provides the inherited information structure, the mitochondrial genome contributes to the regulation of energy production and the response to cellular stress, while the microbiome introduces an additional level of biological complexity through the vast genetic repertoire of the microbial communities associated with the organism.
The human being can therefore be interpreted as a true metaorganism, that is, as a biological system formed by the interaction between human cells, cellular genomes, and numerous microbial ecosystems distributed in the intestine, skin, oral cavity, and other anatomical regions. This view does not replace classical genetics, but expands it: the human phenotype emerges from the interaction between multiple levels of biological information.
The most recent research on aging confirms that genetics, epigenetics, and the environment contribute in an integrated way to the different trajectories of biological age. Studies on centenarians and people with particularly favorable aging have identified genetic variants and pathways associated with biological resilience, stress response, autophagy, metabolic regulation, and cellular stability. However, no genetic variant, considered in isolation, absolutely determines individual longevity. Genetics contributes to defining predispositions and response capacities, while the environment and time continuously modulate the expression of these potentials.
In this scenario, DNA should not be interpreted as a rigid and immutable program. The genetic sequence certainly constitutes a relatively stable element, but its biological use depends on a complex regulatory architecture. The same DNA sequence can be read differently by different cells and at different times in life. A liver cell, a neuron, and an immune cell share almost the same genome, but use profoundly different transcriptional programs.
The main regulatory system that allows this flexibility is represented by the epigenome.
Epigenetics studies the modifications that regulate gene activity without necessarily changing the DNA base sequence. Among the main epigenetic mechanisms are DNA methylation, histone modifications, chromatin structure regulation, and the action of numerous non-coding RNA molecules.
The metaphor according to which the genome represents the hardware and the epigenome the software can be useful from a popular science point of view, provided it is not interpreted literally. The epigenome is not a simple program superimposed on the DNA, but a dynamic network of molecular interactions through which information from the environment, metabolism, and the cellular microenvironment can influence gene transcription.
The cellular microenvironment is, in fact, one of the main points of contact between the organism and the environment. Nutrients, metabolites, hormones, inflammatory mediators, microbial molecules, xenobiotics, and mechanical signals can be recognized by cellular receptors and transformed into intracellular signals. Through signal transduction pathways, these stimuli reach the nucleus and can modify the chromatin structure and the activity of specific genetic programs.
The biological pathway can therefore be represented as a continuous sequence:
environment → surfaces and sensory systems → cellular receptors → signal transduction → metabolism → epigenetic regulation → gene expression → biological phenotype.
This model allows us to understand why the relationship between the genome and the environment is not unidirectional. The organism does not simply undergo the environment, but interprets it through its own biological systems. The response depends on genetic predisposition, age, metabolic state, immune activity, exposure history, and the composition of microbial communities.
To describe the set of environmental exposures that accompany an individual throughout their entire life, the concept of exposome has been introduced. The exposome includes not only the chemicals present in the environment, but also diet, physical activity, sleep, social context, infections, the urban environment, climatic conditions, and numerous other factors that interact with individual biology.
The growing importance of the exposome in the study of aging derives from the observation that many chronic diseases cannot be explained exclusively by the presence of high-risk genetic variants. In most cases, cardiovascular, metabolic, neurodegenerative diseases, and numerous forms of cancer derive from complex networks in which genetic predisposition and environmental factors interact for many years.
The available evidence indicates that chronic exposure to various pollutants can contribute to biological processes associated with aging through oxidative stress, mitochondrial dysfunction, persistent inflammation, and alterations in epigenetic regulation. This does not mean that every exposure automatically produces a disease, but that duration, intensity, the period of life, and individual vulnerability can modify biological risk.
In this context, the concept of a biological susceptibility window takes on particular relevance.
Embryonic life, fetal life, and the first years of development represent periods in which cells and tissues undergo extremely intense processes of proliferation, differentiation, and organization. During these phases, the organism establishes metabolic, endocrine, immune, and neurological programs that can influence future health.
This perspective is at the basis of the Developmental Origins of Health and Disease paradigm, according to which the conditions present in the early stages of development can contribute to modifying the likelihood of developing certain diseases over the course of life.
The so-called fetal programming must, however, be correctly interpreted. It does not represent an inevitable biological destiny. Early developmental modifications can increase or reduce vulnerability to certain conditions, but the final result also depends on subsequent environmental exposures and the individual's genetic characteristics.
Contemporary research is deepening the role of epigenetic modifications as a possible mechanism linking the prenatal environment and future health. Maternal exposures, nutritional status, metabolism, inflammation, air pollutants, and certain toxic substances can be associated with modifications in DNA methylation, microRNA activity, and other regulatory systems.
Environmental epigenetics studies, however, emphasize an essential distinction: the observation of an epigenetic modification associated with a certain exposure does not automatically prove that the modification is the direct cause of a disease. In many cases, longitudinal, experimental, and mechanistic studies are necessary to distinguish causality from simple association.
This caution is particularly important when discussing complex conditions such as obesity, type 2 diabetes, neurodevelopmental disorders, and tumors. These diseases cannot be attributed to a single environmental factor or a single epigenetic modification. Their origin is generally multifactorial and derives from the interaction between numerous biological and social determinants.
The issue of environmental exposure during fetal development remains, however, a research priority. The placenta is not simply a passive barrier, but a biologically active organ involved in the exchange of nutrients, metabolites, and molecular signals between mother and fetus. Alterations in the maternal environment can influence placental function and, through complex mechanisms, contribute to the regulation of development.
Recent literature on the so-called fetal exposome is exploring precisely the possibility that certain exposures during pregnancy contribute to the programming of biological vulnerabilities that can manifest many years later. In particular, modifications in DNA methylation, inflammation, and growth signaling systems represent important areas of research.
The microbiome introduces an additional level of complexity.
The intestine hosts a vast community of microorganisms whose overall genetic makeup, defined as the microbiome, far exceeds that of the individual human genome in functional diversity. Intestinal microorganisms produce metabolites capable of influencing metabolism, the immune system, intestinal barrier function, and communication between different organs.
Among the main biological mediators are short-chain fatty acids, microbiota-modified bile acids, amino acid metabolites, and numerous other bioactive molecules.
A particularly interesting example concerns butyrate and other short-chain fatty acids. These molecules, produced through the fermentation of dietary substrates by specific intestinal microorganisms, can influence cellular metabolism and certain epigenetic regulatory mechanisms, including the activity of enzymes involved in histone modification.
The microbiota therefore represents a biological bridge between diet, environment, and cellular regulation.
However, the composition of microbial communities is not immutable. Diet, medications, antibiotics, infections, physical activity, age, stress, and environmental conditions can alter their structure and functions. Consequently, the microbiome must be considered a dynamic component of the human biological system.
The most recent research on the microbiome and aging describes a bidirectional relationship. Age alters the composition and function of microbial communities, while the metabolites produced by the microbiota can influence immune, metabolic, and endocrine processes involved in aging.
However, there is no single “longevity microbiota” that applies to all individuals. Microbial communities are extremely influenced by geography, diet, genetics, age, and living conditions. For this reason, precision medicine will probably have to move from simply listing microbial species toward understanding metabolic functions and interactions between the microbiota and the host.
In this perspective, genomics necessarily becomes multidimensional.
The study of the nuclear genome alone is no longer sufficient to describe the biological complexity of the individual. Longevity medicine increasingly tends to integrate:
genomics, to identify genetic variants and predispositions;
epigenomics, to assess the regulation of gene expression;
mitogenomics, to study mitochondrial DNA and function;
microbiomics, to analyze microbial communities and their functions;
metabolomics, to identify the end products of metabolic networks;
proteomics, to assess the expression and function of proteins;
exposomics, to reconstruct the complex of environmental exposures.
This integration is often referred to as a multi-omic approach.
The goal is not to produce an ever-increasing amount of data, but to understand how the different biological levels interact with each other. A genetic alteration can modify a metabolic pathway; a metabolic change can influence the epigenome; the epigenome can change gene expression; the microbiota can alter the availability of metabolites; the environment can act simultaneously on all these levels.
Aging therefore emerges as a property of the system.
This perspective also helps explain why people with a similar genetic predisposition can develop very different biological trajectories. The genetic heritage establishes a set of biological possibilities, while cumulative exposures and the body's responses help determine which of these possibilities become predominant.
One of the most studied tools for quantifying this interaction is represented by epigenetic clocks. Through the analysis of specific DNA methylation patterns, it is possible to estimate certain aspects of biological age. The difference between chronological age and estimated biological age can provide information on the speed at which certain molecular processes associated with aging are proceeding.
Epigenetic clocks are extremely interesting tools for research and could play an increasing role in preventive medicine. However, their individual clinical significance must be interpreted with caution. An estimate of biological age does not constitute a diagnosis and does not automatically identify a person's health destiny.
The epigenome is characterized by greater plasticity compared to the genetic sequence, but the concept of reversibility must also be used correctly. Some epigenetic modifications can change over time and respond to changes in the environment and lifestyle, while others can be very stable and depend on cellular history and development.
For this reason, it is not scientifically correct to state that all diseases are simply “reversible” by intervening on the epigenome. However, it is reasonable to state that biological plasticity offers important opportunities for prevention and that many risk factors can be modified.
Primary prevention therefore plays a central role.
Reducing exposure to tobacco smoke, promoting a balanced diet, combating sedentary behavior, maintaining an adequate body weight, improving air quality, and reducing harmful occupational and environmental exposures are interventions that act simultaneously on numerous biological pathways.
The concept of prevention should not be limited to early diagnosis. In fact, the most modern preventive medicine seeks to intervene before biological damage becomes clinically evident.
This principle takes on particular importance during pregnancy and in the early stages of life. The protection of maternal and child health represents one of the most important long-term prevention strategies, not because every exposure inevitably determines a disease, but because the early stages of development constitute periods in which the organism is particularly sensitive to the quality of the environment.
The relationship between the environment and neurodevelopmental disorders is another field in which it is necessary to avoid simplifications.
Autism spectrum disorders, for example, are highly heterogeneous conditions in which numerous genetic and biological factors contribute. Research is studying possible interactions between genetic predisposition, the prenatal environment, maternal immunity, metabolism, and the microbiota. Many observed associations are biologically plausible, but not all are yet sufficiently demonstrated to establish direct causal relationships.
A similar reasoning applies to air pollution, pesticides, certain metals, and other contaminants. For certain exposures, there is solid evidence of toxicity or increased health risk, while for others, the level of evidence remains limited or subject to possible confounding factors.
Complexity is particularly evident also in the field of cancer.
Modern cancer biology no longer considers cancer as the simple result of a single genetic mutation. Carcinogenesis is a complex evolutionary and biological process in which somatic mutations, genomic instability, the tissue microenvironment, immunity, metabolism, and epigenetic alterations interact.
Epigenetic modifications can appear early in neoplastic transformation and contribute to the regulation of genes involved in cell proliferation, differentiation, DNA repair, and apoptosis. However, it would be excessive to state that genetic mutations are simply a late consequence of instability caused by epigenetic modifications.
Current evidence indicates instead a complex bidirectional relationship. Mutations can alter epigenetic systems, and epigenetic alterations can promote conditions that contribute to genomic instability. In different tumors, different mechanisms may predominate at different times.
The interpretation of so-called non-coding DNA has also profoundly changed.
It is correct to state that only a small part of the human genome directly encodes proteins. However, it is not correct to infer that all the remaining DNA necessarily has a defined regulatory function. An important part of the non-coding genome participates in gene regulation and chromosomal structure through regulatory sequences and non-coding RNAs, while the function of other regions remains a subject of study.
The Human Genome Project thus produced a profound cultural shift. It demonstrated that the number of protein-coding genes is much lower than previously expected and that biological complexity derives largely from regulatory systems, the three-dimensional structure of the genome, and the interaction networks between genes and the environment.
The genome can therefore be considered a functionally dynamic system.
The DNA sequence remains relatively stable, but its three-dimensional organization, chromatin availability, and gene expression programs change continuously during development, aging, and response to environmental stimuli.
This conception helps explain the epidemiological transition of recent decades.
In industrialized countries, improvements in hygiene, nutrition, vaccination, and antimicrobial therapies led to a profound reduction in mortality caused by many infectious diseases. At the same time, increased life expectancy altered the population structure and contributed to the growing relative burden of chronic diseases.
This phenomenon cannot be explained solely by pollution or epigenetics. Demographic aging, improved diagnostic capabilities, lifestyle changes, and increased survival all contribute to the current epidemiological landscape.
However, it remains evident that a significant part of the global burden of chronic diseases is associated with modifiable factors.
Smoking, excessive alcohol consumption, physical inactivity, overweight, and poor diet are among the main preventable determinants of non-communicable diseases.
In oncology, Italy has achieved important results in diagnosis and treatment, and survival for many cancers has improved significantly over recent decades. However, the growing absolute number of people living with a cancer diagnosis is also the result of population aging and increased survival.
For this reason, prevention must be considered complementary to precision medicine, not an alternative to it.
Modern genomics makes it possible to identify predispositions and better understand individual differences in response to interventions. Epigenomics allows for the study of the dynamic regulation of genetic activity. Microbiomics analyzes a fundamental component of the human ecosystem. Exposomics makes it possible to consider the impact of environmental history.
Their integration can open a new phase of medicine.
The central concept is not that of an individual defined exclusively by their genes, but that of a biologically dynamic organism, continuously shaped by the interaction between genetic information, metabolism, microbiota, and the environment.
Longevity can therefore be interpreted not only as the result of time passed, but as the organism's ability to maintain resilience and adaptation despite the progressive accumulation of biological stress.
In this perspective, genomics represents the fusion of different fields because it makes it possible to connect disciplines that were previously considered separate: genetics, molecular biology, microbiology, nutrition, toxicology, epidemiology, and preventive medicine.
The real challenge of longevity medicine will probably be to understand not only which genes we possess, but how they are used over time, in what environment we live, what metabolic signals we produce, which microbial communities accompany us, and how all these elements interact in shaping our biological age.
Future prevention cannot therefore rely exclusively on the search for a single mutation or a single risk factor. It will increasingly need to be able to read the person as an integrated biological system.
It is in this transition from the single molecule to the network, from the isolated gene to the interaction between genome, epigenome, microbiome, and exposome, that genomics finds one of its most important applications in understanding longevity and building personalized prevention strategies.
Bibliographic references
- Dutta A, et al. Genetic, epigenetic and environmental determinants of ageing. Ageing Research Reviews. Recent literature on the molecular basis of aging.
- Decoding human longevity: Genetic and molecular insights from accelerated to successful ageing. Ageing Research Reviews. 2026;119:103176. Review of genetic variants associated with accelerated aging and exceptional longevity.
- Ticinesi A, Maggi S, Nouvenne A, Zuliani G, Franceschi C, et al. The gut microbiome and ageing trajectories: mechanisms and clinical implications. Nature Reviews Endocrinology. 2026;22:323-337.
- Environmental epigenetics: new horizons in redefining biological and health outcomes. Environment International. 2026;208:110072. Review of the mechanisms through which environmental exposures can influence epigenetic regulation and health.
- Ageing Trajectories: Exposome-Driven Pathobiological Mechanisms and Implications for Prevention from Blue Zones and Italian Longevity Hotspots Such as Cilento and Sicilian Mountain Villages. International Journal of Molecular Sciences. 2025;26(10):4796.
- Faa G, Ziranu P, Pretta A, et al. The impact of the fetal exposome as a predictor of cancer risk in childhood and adulthood. Aberrant epigenetic events occurring during gestation: May they trigger fetal programming of cancer risk later in life? International Journal of Gynecology & Obstetrics. 2025.
- Epigenetic mechanisms linking the perinatal environment, the placenta, and maternal and child health outcomes: evidence for sexual dimorphism. Environmental Epigenetics. 2026;12(1).
- Cross-generational mechanisms of maternal gut microbiota in modulating offspring autism spectrum disorder risk: from the gut-brain axis to translational challenges in precision interventions. Frontiers in Aging Neuroscience. 2025.
- Personalized Medicine in Autism Spectrum Disorder: Integrating Epigenomics, Microbiome Research and Early Diagnostics. International Journal of Developmental Neuroscience. 2026.
- Gut microbiota-epigenetic interactions in systemic aging: mechanistic drivers for endocrine and reproductive network remodeling and therapeutic modulation. Frontiers in Aging. 2026.
- International Agency for Research on Cancer. Environmental Exposure and Risk of Childhood Leukemia: An Overview. Summary of available evidence on environmental factors and the risk of childhood leukemia.
- International Agency for Research on Cancer. Childhood Cancer. Global epidemiological data on childhood cancers.
